Viking Therapeutics (VKTX) Q4 2023 Earnings

7FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.26
-0.24
-0.21
-0.19

Details

Expected EPS
-0.26
Actual EPS
-0.25
Surprise EPS
0.01
Surprise Percent
+3.85%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.25 per share for Q4 2023.

0 Comments

Share your thoughts